5-[(2-chlorophenyl)sulfanyl]-6'-[(3,4-difluorophenyl)amino]-4-hydroxy-2-{6-[(oxan-4-yl)amino]pyridin-2-yl}-1,2,3,6-tetrahydro-[2,2'-bipyridin]-6-one

ID: ALA5196929

Chembl Id: CHEMBL5196929

PubChem CID: 168288107

Max Phase: Preclinical

Molecular Formula: C32H28ClF2N5O3S

Molecular Weight: 636.12

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1NC(c2cccc(Nc3ccc(F)c(F)c3)n2)(c2cccc(NC3CCOCC3)n2)CC(O)=C1Sc1ccccc1Cl

Standard InChI:  InChI=1S/C32H28ClF2N5O3S/c33-21-5-1-2-6-25(21)44-30-24(41)18-32(40-31(30)42,26-7-3-9-28(38-26)36-19-13-15-43-16-14-19)27-8-4-10-29(39-27)37-20-11-12-22(34)23(35)17-20/h1-12,17,19,41H,13-16,18H2,(H,36,38)(H,37,39)(H,40,42)

Standard InChI Key:  UQAJBRWEKKALSW-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5196929

    ---

Associated Targets(Human)

LDHA Tchem L-lactate dehydrogenase A chain (1573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
LDHB Tchem L-lactate dehydrogenase B chain (463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 636.12Molecular Weight (Monoisotopic): 635.1569AlogP: 7.07#Rotatable Bonds: 8
Polar Surface Area: 108.40Molecular Species: ACIDHBA: 8HBD: 4
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 5.60CX Basic pKa: 6.23CX LogP: 4.67CX LogD: 3.70
Aromatic Rings: 4Heavy Atoms: 44QED Weighted: 0.16Np Likeness Score: -1.07

References

1. Wei B, Robarge K, Labadie SS, Chen J, Corson LB, DiPasquale A, Dragovich PS, Eigenbrot C, Evangelista M, Fauber BP, Hitz A, Hong R, Lai KW, Liu W, Ma S, Malek S, O'Brien T, Pang J, Peterson D, Salphati L, Sampath D, Sideris S, Ultsch M, Xu Z, Yen I, Yu D, Yue Q, Zhou A, Purkey HE..  (2022)  Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase.,  59  [PMID:35065235] [10.1016/j.bmcl.2022.128576]
2. Wei B, Robarge K, Labadie SS, Chen J, Corson LB, DiPasquale A, Dragovich PS, Eigenbrot C, Evangelista M, Fauber BP, Hitz A, Hong R, Lai KW, Liu W, Ma S, Malek S, O'Brien T, Pang J, Peterson D, Salphati L, Sampath D, Sideris S, Ultsch M, Xu Z, Yen I, Yu D, Yue Q, Zhou A, Purkey HE..  (2022)  Structure-based optimization of hydroxylactam as potent, cell-active inhibitors of lactate dehydrogenase.,  59  [PMID:35065235] [10.1016/j.bmcl.2022.128576]

Source